Tatebayashi Kotaro, Nakayama Noriyuki, Sakamoto Daisuke, Iida Tomoko, Ono Shun, Matsuda Ikuo, Enomoto Yukiko, Tanaka Michihiro, Fujita Mitsugu, Hirota Seiichi, Yoshimura Shinichi
Department of Neurosurgery, Hyogo Medical University, Nishinomiya 663-8501, Japan.
Department of Neurosurgery, Gifu University, Gifu 501-1112, Japan.
Cancers (Basel). 2023 Jul 26;15(15):3800. doi: 10.3390/cancers15153800.
Preoperative angiography in glioblastoma (GBM) often shows arteriovenous shunts and early venous filling (EVF). Here, we investigated the clinical implications of EVF in GBM as a prognostic and vascular mimicry biomarker. In this retrospective multicenter study, we consecutively enrolled patients who underwent angiography with a GBM diagnosis between 1 April 2013 and 31 March 2021. The primary and secondary endpoints were the differences in overall survival (OS) and progression-free survival (PFS), respectively, between cases with and without EVF. Of the 133 initially enrolled patients, 91 newly diagnosed with GBM underwent preoperative angiography and became the study population. The 6-year OS and PFS were significantly worse in the EVF than in the non-EVF group. Moreover, 20 GBM cases (10 with EVF and 10 without EVF) were randomly selected and evaluated for histological vascular mimicry. Except for two cases that were difficult to evaluate, the EVF group had a significantly higher frequency of vascular mimicry than the non-EVF group (0/8 vs. 5/10, = 0.04). EVF on preoperative angiography is a robust prognostic biomarker for GBM and may help detect cases with a high frequency of histological vascular mimicry.
胶质母细胞瘤(GBM)的术前血管造影通常显示动静脉分流和早期静脉充盈(EVF)。在此,我们研究了GBM中EVF作为一种预后和血管拟态生物标志物的临床意义。在这项回顾性多中心研究中,我们连续纳入了2013年4月1日至2021年3月31日期间接受血管造影且诊断为GBM的患者。主要和次要终点分别是有和没有EVF的病例之间总生存期(OS)和无进展生存期(PFS)的差异。在最初纳入的133例患者中,91例新诊断为GBM的患者接受了术前血管造影并成为研究人群。EVF组的6年OS和PFS明显比非EVF组差。此外,随机选择20例GBM病例(10例有EVF,10例无EVF)并评估组织学血管拟态。除了2例难以评估的病例外,EVF组的血管拟态频率明显高于非EVF组(0/8 vs. 5/10,P = 0.04)。术前血管造影上的EVF是GBM的一种可靠预后生物标志物,可能有助于检测组织学血管拟态频率高的病例。